Search

everythinglearnresearchcommunity

for

Search:↓

Psoriasis is a common skin disorder caused by immune system issues, treatable with various therapies.

Burn injuries in mice heal similarly to humans, with inflammation and cell changes normalizing over time.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

Clascoterone 1% cream is a promising new treatment for acne.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Recognizing skin symptoms can help diagnose and manage COVID-19.

Leptin-deficient mice, used as a model for Type 2 Diabetes, have delayed wound healing due to impaired contraction and other dysfunctional cellular responses.

Skin has a larger surface area than thought, certain skin cells improve skin flap survival, better trials for skin conditions in children are needed, Stevens-Johnson syndrome rates vary by age and race, and better skin barrier function may reduce inflammation in the elderly.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

New cytokine-targeted therapies show promise for treating alopecia areata.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Laser hair removal is safe for people with Systemic Lupus Erythematosus.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Higher leptin levels link to hair loss.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Protein-losing enteropathy worsened with lupus symptoms but improved with prednisolone.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Effective treatments for severe alopecia areata are still lacking.